ConductScience.org, home

Trial · NCT07914608

OPTIMAL Motor Learning in Table Tennis: A fNIRS Study

NCT07914608, Not applicable, Not yet recruiting, National Yang Ming Chiao Tung University

3 sourcestrials-2026-11-12-0.5.0

Download JSON
Cite this record

ConductScience Library. OPTIMAL Motor Learning in Table Tennis: A fNIRS Study. Trials, record NCT07914608. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07914608

On this page

Trial

As registered on ClinicalTrials.gov, in the graph's capture of the registry.

Title
OPTIMAL Motor Learning in Table Tennis: A fNIRS Study
NCT number
NCT07914608
Status
Not yet recruiting
Phases
Not applicable
Enrollment
90 participants, estimated
Lead sponsor
National Yang Ming Chiao Tung University
Conditions
Motor Learning, Aging, Coginitive Dysfunction
Interventions
OPTIMAL theory-based Instruction, Conventional Instruction (Control)
First posted
2026-11-03
Last updated
2026-11-03

Source ClinicalTrials.gov

Registered outcomes7

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescription
PrimaryMotor Performance (Accuracy Score)
Day 1 Pre-test: before practice (3 blocks) Acquisition: during practice (15 blocks) Post-test: immediately after practice (3 blocks) Day 2 Retention test: at least 24 hours after Day 1 (3 blocks) Transfer test: at least 24 hours after Day 1 (3 blocks)
Accuracy is measured with a target-centered scoring system on a 0-7 scale per ball; higher scores indicate better accuracy. 7 pts: Hit target (10 cm diameter). 6 pts: Hit zone (20 cm). 5 pts: Hit zone (30 cm). 4 pts: Hit zone (40 cm). 3 pts: Hit zone (50 cm). 2 pts: Hit opposite table surface but missed target zones. 1 pt: Ball was hit but missed the opposite table. 0 pts: Failed to hit the ball. The performance is presented by blocks. Each block contains 30 balls. The average score of each block is calculated.
SecondaryPrefrontal Cortex (DLPFC) Activation
Day 1 Pre-test: before practice (3 blocks) Acquisition: during practice (15 blocks) Post-test: immediately after practice (3 blocks) Day 2 Retention test: at least 24 hours after Day 1 (3 blocks) Transfer test: at least 24 hours after Day 1 (3 blocks)
Change in oxygenated hemoglobin (HbO) concentration (μM) in the bilateral dorsolateral prefrontal cortex (DLPFC), measured using functional near-infrared spectroscopy (fNIRS) during table tennis backhand task blocks.
SecondaryPremotor Cortex (PMC) Activation
Day 1 Pre-test: before practice (3 blocks) Acquisition: during practice (15 blocks) Post-test: immediately after practice (3 blocks) Day 2 Retention test: at least 24 hours after Day 1 (3 blocks) Transfer test: at least 24 hours after Day 1 (3 blocks)
Change in oxygenated hemoglobin (HbO) concentration (μM) in the bilateral premotor cortex (PMC), measured using functional near-infrared spectroscopy (fNIRS) during table tennis backhand task blocks.
SecondarySupplementary Motor Area (SMA) Activation
Day 1 Pre-test: before practice (3 blocks) Acquisition: during practice (15 blocks) Post-test: immediately after practice (3 blocks) Day 2 Retention test: at least 24 hours after Day 1 (3 blocks) Transfer test: at least 24 hours after Day 1 (3 blocks)
Change in oxygenated hemoglobin (HbO) concentration (μM) in the supplementary motor area (SMA), measured using functional near-infrared spectroscopy (fNIRS) during table tennis backhand task blocks.
SecondarySensorimotor Cortex (SMC) Activation
Day 1 Pre-test: before practice (3 blocks) Acquisition: during practice (15 blocks) Post-test: immediately after practice (3 blocks) Day 2 Retention test: at least 24 hours after Day 1 (3 blocks) Transfer test: at least 24 hours after Day 1 (3 blocks)
Change in oxygenated hemoglobin (HbO) concentration (μM) in the sensorimotor cortex (SMC), measured using functional near-infrared spectroscopy (fNIRS) during table tennis backhand task blocks.
SecondarySelf-Efficacy (General Self-Efficacy Scale, GSES)Day 1 Immediately after Pre-test
Self-efficacy is measured with the General Self-Efficacy Scale (GSES), a 10-item self-report scale. Each item is rated from 1 (not at all true) to 4 (exactly true), giving a total score of 10 to 40; higher scores indicate higher self-efficacy.
OtherManipulation CheckDay 1 After Post-test Day 2 After Transfer test
A questionnaire verifying whether participants perceived the assigned experimental manipulations (autonomy support, enhanced expectancies, and attentional focus). It consists of 19 items rated mainly on 0-10 scales (items 10-11 on a 0-100% scale); higher scores indicate stronger agreement or greater perception of the corresponding construct.

Outcomes0

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

None in this release.

Results by group0

Each measurement the trial posted, group by group, in the words and numbers it posted.

None in this release.

Participant flow0

How many started, completed or left each group, period by period.

None in this release.

Adverse events0

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

None in this release.

Adverse event totals0

The totals the trial posted for each group.

None in this release.

Papers0

The papers the trial lists on ClinicalTrials.gov.

None in this release.

Grants0

The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.

None in this release.

Trial comparisons0

Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.

None in this release.

Tests0

The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.

None in this release.

Data dates

The day each source was copied for this release.

ClinicalTrials.gov
2026-11-12
ClinicalTrials.gov
Results, from AACT
2026-03-23
AACT
NIH grant links
2026-11-13
NIH RePORTER

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this trial from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/trials/v1/NCT07914608

GET https://conductscience.org/api/trials/v1/NCT07914608/registered